Brief: ChemoCentryx Reports Qtrly Loss Per Share $0.32
Nov 9 (Reuters) - ChemoCentryx Inc CCXI.O :
* CHEMOCENTRYX REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
RECENT HIGHLIGHTS
* Q3 REVENUE $17.7 MILLION
* $372 MILLION IN CASH AND INVESTMENTS AT SEPTEMBER 30, 2021
* EXPECTS TO END YEAR WITH CASH, CASH EQUIVALENTS AND
INVESTMENTS
IN EXCESS OF $360 MILLION
* QTRLY LOSS PER SHARE $0.32
* Q3 EARNINGS PER SHARE VIEW $-0.45, REVENUE VIEW $13.5
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2zCt2Z
Further company coverage: CCXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Churchill Capital XI
See all newsBrief: AGCO To Pilot Digit Humanoid Robot At Hesston, Kansas Facility In 2027
Brief: Agility Robotics Announces Audit Committee Chair For Planned Public-Company Board
Brief: Agility Robotics And Churchill Capital Corp Xi S-4 Registration Statement Declared Effective By SEC In Connection With Proposed Business Combination
Brief: Agility And Fort Robotics Announce Strategic Partnership To Advance Humanoid Robot Safety
Deals of the day-Mergers and acquisitions